Depression Linked With Risks of Vascular Disease & Mortality in MS
“Depression is the most frequent comorbidity for people with MS, affecting more than 20% of this...
Breaking Psychiatry
Smartphone App for Patients With Psoriasis Proves Beneficial
“eHealth devices are becoming increasingly popular among dermatologists and their patients,”...
Network Changes & Cognitive Impairment in MS
“Cognitive impairment in patients with multiple sclerosis (MS) is related to functional network...
Examining Characteristics Linked With Poor Outcomes in Opioid Prescribing
“In recent decades, the medical community has become acutely aware of the dangers posed by...
Examining Why Patients With Chronic Hepatitis C Drink Alcohol
The burden of chronic liver disease in the United States is substantial, affecting about 4.5...
Examining Long-Term Sexual Outcomes With Exstrophy-Epispadias
“For children with exstrophy-epispadias complex (EEC), a spectrum of genitourinary malformation,...
COVID-19 Had Major Impact on ICU Nurses’ Mental Health
MONDAY, May 24, 2021 (HealthDay News) — Nurses who worked in the intensive care unit (ICU)...
Nearly 10 Percent of Students Report Being Gender-Diverse
TUESDAY, May 18, 2021 (HealthDay News) — Overall, 9.2 percent of high school students report...
App-Based Mental Health Services Demonstrate Efficacy in Trio of Trials
Internet- and smartphone-based care helped with pediatric OCD, depression in adults Mental health interventions delivered online or via a smartphone showed promise for treating kids with obsessive-compulsive disorder (OCD) and...
Assessing Drug Overdose Risk Among People With HIV
Preventable deaths, including those due to drug overdose (OD), are a significant public health...
FDA OKs Higher Naloxone Dose for Opioid Overdose
New product doubles typical naloxone dose The FDA approved an 8 mg-dose naloxone hydrochloride nasal spray (Kloxxado) to treat opioid overdose, doubling the allowable naloxone dose that was previously capped at 4 mg per spray...
AMA Applauds HHS Move to Expand Treatment for Opioid Use Disorder
New guidelines remove waiver requirement for buprenorphine treatment The American Medical Association (AMA) praised a move from the Department of Health and Human Services (HHS) to remove training requirements for physicians to...
